Haw Par Corporation Limited
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases… Read more
Market Cap & Net Worth: Haw Par Corporation Limited (HAWPF)
Haw Par Corporation Limited (PINK:HAWPF) has a market capitalization of $1.85 Billion ($1.85 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #6696 globally and #3704 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Haw Par Corporation Limited's stock price $8.37 by its total outstanding shares 221368173 (221.37 Million).
Haw Par Corporation Limited Market Cap History: 2015 to 2025
Haw Par Corporation Limited's market capitalization history from 2015 to 2025. Data shows growth from $959.70 Million to $1.85 Billion (7.26% CAGR).
Haw Par Corporation Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Haw Par Corporation Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.55x
Haw Par Corporation Limited's market cap is 7.55 times its annual revenue
0.84x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
8.10x
Haw Par Corporation Limited's market cap is 8.10 times its annual earnings
11.15x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $959.70 Million | $178.83 Million | $183.28 Million | 5.37x | 5.24x |
| 2016 | $1.08 Billion | $201.64 Million | $125.04 Million | 5.34x | 8.61x |
| 2017 | $1.40 Billion | $222.76 Million | $122.46 Million | 6.29x | 11.44x |
| 2018 | $1.52 Billion | $237.81 Million | $179.07 Million | 6.37x | 8.46x |
| 2019 | $1.83 Billion | $243.99 Million | $182.21 Million | 7.49x | 10.03x |
| 2020 | $1.59 Billion | $111.03 Million | $119.77 Million | 14.30x | 13.26x |
| 2021 | $1.65 Billion | $141.18 Million | $110.10 Million | 11.66x | 14.96x |
| 2022 | $1.54 Billion | $182.09 Million | $148.32 Million | 8.48x | 10.41x |
| 2023 | $1.61 Billion | $232.06 Million | $216.57 Million | 6.92x | 7.41x |
| 2024 | $1.85 Billion | $244.82 Million | $228.27 Million | 7.55x | 8.10x |
Competitor Companies of HAWPF by Market Capitalization
Companies near Haw Par Corporation Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Haw Par Corporation Limited by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Haw Par Corporation Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, Haw Par Corporation Limited's market cap moved from $959.70 Million to $ 1.85 Billion, with a yearly change of 7.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.85 Billion | +0.24% |
| 2024 | $1.85 Billion | +15.11% |
| 2023 | $1.61 Billion | +4.00% |
| 2022 | $1.54 Billion | -6.24% |
| 2021 | $1.65 Billion | +3.70% |
| 2020 | $1.59 Billion | -13.09% |
| 2019 | $1.83 Billion | +20.54% |
| 2018 | $1.52 Billion | +8.23% |
| 2017 | $1.40 Billion | +30.02% |
| 2016 | $1.08 Billion | +12.24% |
| 2015 | $959.70 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Haw Par Corporation Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.85 Billion USD |
| MoneyControl | $1.85 Billion USD |
| MarketWatch | $1.85 Billion USD |
| marketcap.company | $1.85 Billion USD |
| Reuters | $1.85 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.